HilleVax Statistics
Total Valuation
HilleVax has a market cap or net worth of $72.36 million. The enterprise value is -$68.65 million.
Important Dates
The last earnings date was Friday, March 28, 2025, after market close.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HilleVax has 49.22 million shares outstanding. The number of shares has increased by 21.07% in one year.
| Current Share Class | 49.22M |
| Shares Outstanding | 49.22M |
| Shares Change (YoY) | +21.07% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 3.76% |
| Owned by Institutions (%) | 51.87% |
| Float | 30.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.84, with a Debt / Equity ratio of 0.16.
| Current Ratio | 10.84 |
| Quick Ratio | 10.42 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -32.24 |
Financial Efficiency
Return on equity (ROE) is -70.13% and return on invested capital (ROIC) is -26.97%.
| Return on Equity (ROE) | -70.13% |
| Return on Assets (ROA) | -24.89% |
| Return on Invested Capital (ROIC) | -26.97% |
| Return on Capital Employed (ROCE) | -60.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.64M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.82% in the last 52 weeks. The beta is 0.79, so HilleVax's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -89.82% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 2.87 |
| Relative Strength Index (RSI) | 28.66 |
| Average Volume (20 Days) | 136,849 |
Short Selling Information
The latest short interest is 1.59 million, so 3.23% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.62M |
| Short % of Shares Out | 3.23% |
| Short % of Float | 5.29% |
| Short Ratio (days to cover) | 11.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -106.96M |
| Pretax Income | -156.27M |
| Net Income | -147.27M |
| EBITDA | -105.08M |
| EBIT | -106.96M |
| Earnings Per Share (EPS) | -$3.00 |
Full Income StatementBalance Sheet
The company has $171.43 million in cash and $24.51 million in debt, giving a net cash position of $146.92 million or $2.98 per share.
| Cash & Cash Equivalents | 171.43M |
| Total Debt | 24.51M |
| Net Cash | 146.92M |
| Net Cash Per Share | $2.98 |
| Equity (Book Value) | 154.49M |
| Book Value Per Share | 3.16 |
| Working Capital | 161.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$108.79 million and capital expenditures -$522,000, giving a free cash flow of -$109.31 million.
| Operating Cash Flow | -108.79M |
| Capital Expenditures | -522,000 |
| Free Cash Flow | -109.31M |
| FCF Per Share | -$2.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |